14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.

      Circulation. Cardiovascular quality and outcomes
      Ovid Technologies (Wolters Kluwer Health)
      C-reactive protein, coronary disease, homocysteine, risk factors

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The relationship of circulating levels of high-sensitivity C-reactive protein (CRP) with cardiovascular disease (CVD) risk, particularly with consideration of effects at intermediate levels of risk, has not been fully assessed.

          Related collections

          Author and article information

          Journal
          20031795
          3033831
          10.1161/CIRCOUTCOMES.108.831198

          C-reactive protein,coronary disease,homocysteine,risk factors

          Comments

          Comment on this article

          scite_